{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:01:03Z","timestamp":1793113263546,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jfma.2024.09.022","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T07:51:27Z","timestamp":1728114687000},"page":"S63-S69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Blood pressure targets, medication consideration and unique concerns in elderly hypertension IV: Focus on frailty, orthostatic hypotension, and resistant hypertension"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6862-5691","authenticated-orcid":false,"given":"Po-Sheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-7986","authenticated-orcid":false,"given":"Chia-Ter","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hao","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hsiang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Fan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Teng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6029-5520","authenticated-orcid":false,"given":"Kuo-Chin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Chih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Kuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Yu-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-2243","authenticated-orcid":false,"given":"Ding-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.arr.2010.09.001","article-title":"Outcome instruments to measure frailty: a systematic review","volume":"10","author":"de Vries","year":"2011","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.022_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03324545","article-title":"Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty","volume":"16","author":"Leng","year":"2004","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"10.1016\/j.jfma.2024.09.022_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2265.2005.02355.x","article-title":"Endocrine and inflammatory markers as predictors of frailty","volume":"63","author":"Puts","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.jfma.2024.09.022_bib9","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/jgs.14876","article-title":"Inflammatory markers and frailty in long-term care residents","volume":"65","author":"Langmann","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2024.09.022_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1196\/annals.1351.021","article-title":"Inflammation and sex hormone metabolism","volume":"1069","author":"Schmidt","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"Spec No","key":"10.1016\/j.jfma.2024.09.022_bib11","first-page":"73","article-title":"Sarcopenia in aging humans: the impact of menopause and disease","volume":"50","author":"Poehlman","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1016\/j.jfma.2024.09.022_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1532-5415.2007.01121.x","article-title":"Testosterone, sex hormone-binding globulin, and frailty in older men","volume":"55","author":"Mohr","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.jfma.2024.09.022_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/gerona\/glp013","article-title":"Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices","volume":"64","author":"Varadhan","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"10.1016\/j.jfma.2024.09.022_bib1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s12603-023-2035-5","article-title":"Global prevalence and factors associated with frailty among community-dwelling older adults with hypertension: a systematic review and meta-analysis","volume":"27","author":"Liu","year":"2023","journal-title":"J Nutr Health Aging"},{"issue":"12","key":"10.1016\/j.jfma.2024.09.022_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024406","article-title":"Hypertension and frailty: a systematic review and meta-analysis","volume":"8","author":"Vetrano","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jfma.2024.09.022_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.arr.2017.01.003","article-title":"Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis","volume":"35","author":"Veronese","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jfma.2024.09.022_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","volume":"13","author":"Warwick","year":"2015","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.jfma.2024.09.022_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"7","key":"10.1016\/j.jfma.2024.09.022_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCULATIONAHA.123.064003","article-title":"The effect of frailty on the efficacy and safety of intensive blood pressure control: a post hoc analysis of the SPRINT trial","volume":"148","author":"Wang","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2024.09.022_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101304","article-title":"Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)","volume":"45","author":"O'Donoghue","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib22","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"10.1016\/j.jfma.2024.09.022_bib19","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.jfma.2024.09.022_bib20","first-page":"600","article-title":"STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation","volume":"46","author":"Lavan","year":"2017","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.022_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ageing\/afaa159","article-title":"Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2","volume":"50","author":"Curtin","year":"2021","journal-title":"Age Ageing"},{"issue":"11","key":"10.1016\/j.jfma.2024.09.022_bib23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2340\/16501977-0424","article-title":"Frailty and incidence of activities of daily living disability among older Mexican Americans","volume":"41","author":"Al Snih","year":"2009","journal-title":"J Rehabil Med"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1532-5415.2008.02136.x","article-title":"Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study","volume":"57","author":"Avila-Funes","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.022_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1532-5415.2009.02671.x","article-title":"Physical frailty is associated with incident mild cognitive impairment in community-based older persons","volume":"58","author":"Boyle","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.jfma.2024.09.022_bib27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/gerona\/62.7.738","article-title":"A comparison of two approaches to measuring frailty in elderly people","volume":"62","author":"Rockwood","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.mad.2006.12.004","article-title":"Cumulative index of health disorders as an indicator of aging-associated processes in the elderly: results from analyses of the National Long Term Care Survey","volume":"128","author":"Kulminski","year":"2007","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12877-022-03287-x","article-title":"Validation of clinical frailty scale in Chinese translation","volume":"22","author":"Chou","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jfma.2024.09.022_bib30","series-title":"Operation manual for the inpatient and outpatient elderly Care in Hospitals","author":"Chang","year":"2022"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib31","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/HYP.0000000000000236","article-title":"Orthostatic hypotension in adults with hypertension: a scientific statement from the American heart association","volume":"81","author":"Juraschek","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2024.09.022_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/1179546820953415","article-title":"Neurogenic orthostatic hypotension: state of the art and therapeutic strategies","volume":"14","author":"Kalra","year":"2020","journal-title":"Clin Med Insights Cardiol"},{"issue":"12","key":"10.1016\/j.jfma.2024.09.022_bib37","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1111\/jgs.18573","article-title":"Timing of orthostatic hypotension and its relationship with falls in older adults","volume":"71","author":"Petriceks","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/HJH.0b013e32834ed663","article-title":"Hypertension and orthostatic hypotension in older patients","volume":"30","author":"Judd","year":"2012","journal-title":"J Hypertens"},{"issue":"11","key":"10.1016\/j.jfma.2024.09.022_bib32","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/HYPERTENSIONAHA.122.18557","article-title":"Orthostatic hypotension in hypertensive adults: harry goldblatt award for early career investigators 2021","volume":"79","author":"Raber","year":"2022","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jfma.2024.09.022_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/HJH.0000000000002411","article-title":"The triad of orthostatic hypotension, blood pressure variability, and arterial stiffness: a new syndrome?","volume":"38","author":"Ram","year":"2020","journal-title":"J Hypertens"},{"issue":"9215","key":"10.1016\/j.jfma.2024.09.022_bib34","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0140-6736(05)72549-6","article-title":"Blood pressure variability in elderly patients","volume":"355","author":"Kario","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/HJH.0b013e32834d3d73","article-title":"Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study","volume":"30","author":"Valbusa","year":"2012","journal-title":"J Hypertens"},{"issue":"8","key":"10.1016\/j.jfma.2024.09.022_bib39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.11622\/smedj.2016135","article-title":"Orthostatic hypotension: prevalence and associated risk factors among the ambulatory elderly in an Asian population","volume":"57","author":"Zhu","year":"2016","journal-title":"Singap Med J"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jash.2011.08.008","article-title":"Orthostatic hypotension: a common, serious and underrecognized problem in hospitalized patients","volume":"6","author":"Feldstein","year":"2012","journal-title":"J Am Soc Hypertens"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib35","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.7861\/clinmed.2020-1044","article-title":"Orthostatic hypotension in older people: considerations, diagnosis and management","volume":"21","author":"Dani","year":"2021","journal-title":"Clin Med (Lond)"},{"issue":"Pt 1","key":"10.1016\/j.jfma.2024.09.022_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-7793.1999.0001o.x","article-title":"Pathophysiological basis of orthostatic hypotension in autonomic failure","volume":"519","author":"Smit","year":"1999","journal-title":"J Physiol"},{"issue":"11","key":"10.1016\/j.jfma.2024.09.022_bib43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","article-title":"Orthostatic hypotension: JACC state-of-the-art review","volume":"72","author":"Freeman","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.022_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/clc.23303","article-title":"Hypertension in older adults: assessment, management, and challenges","volume":"43","author":"Oliveros","year":"2020","journal-title":"Clin Cardiol"},{"issue":"13 Suppl","key":"10.1016\/j.jfma.2024.09.022_bib45","first-page":"s248","article-title":"Neurogenic orthostatic hypotension: pathophysiology and diagnosis","volume":"21","author":"Low","year":"2015","journal-title":"Am J Manag Care"},{"issue":"9","key":"10.1016\/j.jfma.2024.09.022_bib46","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1007\/s00415-012-6736-7","article-title":"Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management","volume":"260","author":"Metzler","year":"2013","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010573","article-title":"Orthostatic hypotension: management of a complex, but common, medical problem","volume":"15","author":"Fedorowski","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.022_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1509723","article-title":"Baroreflex dysfunction","volume":"382","author":"Kaufmann","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jfma.2024.09.022_bib49","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.jamda.2021.07.010","article-title":"Orthostatic hypotension is a risk factor for falls among older adults: 3-year follow-up","volume":"22","author":"Hohtari-Kivim\u00e4ki","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"22","key":"10.1016\/j.jfma.2024.09.022_bib50","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/2013.jamainternmed.469","article-title":"The risk of hip fracture after initiating antihypertensive drugs in the elderly","volume":"172","author":"Butt","year":"2012","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000255459","article-title":"Orthostatic hypotension and cognitive function: the atherosclerosis risk in Communities study","volume":"34","author":"Rose","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib52","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.119.14309","article-title":"Orthostatic hypotension, cardiovascular outcomes, and adverse events: results from SPRINT","volume":"75","author":"Juraschek","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib53","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/HYPERTENSIONAHA.119.14474","article-title":"Orthostatic hypotension and intensive blood pressure treatment: No need to worry?","volume":"75","author":"Niiranen","year":"2020","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.jfma.2024.09.022_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003821","article-title":"Drug-induced orthostatic hypotension: a systematic review and meta-analysis of randomised controlled trials","volume":"18","author":"Bhanu","year":"2021","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.jfma.2024.09.022_bib55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40266-020-00796-5","article-title":"Drug-related orthostatic hypotension: beyond anti-hypertensive medications","volume":"37","author":"Rivasi","year":"2020","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/CON.0000000000000816","article-title":"Management of orthostatic hypotension","volume":"26","author":"Palma","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/jch.14640","article-title":"Associated factors and hemodynamic characteristics of resistant hypertension in the elderly","volume":"25","author":"Geng","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.022_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cger.2009.01.006","article-title":"Resistant hypertension in the elderly","volume":"25","author":"Rafey","year":"2009","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib62","article-title":"Secondary hypertension as a cause of treatment resistance","volume":"32","author":"Sudano","year":"2023","journal-title":"Blood Pres"},{"issue":"4","key":"10.1016\/j.jfma.2024.09.022_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41371-021-00631-3","article-title":"Revisiting the diagnosis of 'resistant hypertension': what should we do nowadays'","volume":"36","author":"Alsharari","year":"2022","journal-title":"J Hum Hypertens"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib57","first-page":"225","article-title":"Guidelines of the taiwan society of cardiology and the taiwan hypertension society for the management of hypertension","volume":"38","author":"Wang","year":"2022","journal-title":"Acta Cardiol Sin"},{"issue":"25","key":"10.1016\/j.jfma.2024.09.022_bib58","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American heart association professional education committee of the council for high blood pressure research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jfma.2024.09.022_bib59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4330\/wjc.v4.i5.135","article-title":"Hypertension in the elderly","volume":"4","author":"Lionakis","year":"2012","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jfma.2024.09.022_bib63","doi-asserted-by":"crossref","first-page":"j3984","DOI":"10.1136\/bmj.j3984","article-title":"Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015","volume":"358","author":"Sinnott","year":"2017","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jfma.2024.09.022_bib64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/10641963.2018.1545852","article-title":"Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study","volume":"41","author":"Wu","year":"2019","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41440-021-00757-4","article-title":"Association of treatment-resistant hypertension defined by home blood pressure monitoring with cardiovascular outcome","volume":"45","author":"Narita","year":"2022","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.022_bib66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41440-021-00801-3","article-title":"Treatment-resistant hypertension assessed by home blood pressure monitoring: a new target for intervention?","volume":"45","author":"Nagai","year":"2022","journal-title":"Hypertens Res"},{"issue":"6","key":"10.1016\/j.jfma.2024.09.022_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/10641963.2018.1510945","article-title":"Resistant hypertension in elderly: a clinical manifestation of heart failure with preserved ejection fraction? retrospective single-center analysis","volume":"41","author":"Turkoglu","year":"2019","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.jfma.2024.09.022_bib70","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/CIA.S5242","article-title":"Management of hypertension in the elderly patient","volume":"4","author":"Stokes","year":"2009","journal-title":"Clin Interv Aging"},{"issue":"7","key":"10.1016\/j.jfma.2024.09.022_bib71","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.118.312156","article-title":"Treatment of resistant and refractory hypertension","volume":"124","author":"Acelajado","year":"2019","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jfma.2024.09.022_bib73","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.114.04116","article-title":"Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension","volume":"64","author":"Okamoto","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bcpt.13248","article-title":"Nebivolol in the treatment of arterial hypertension","volume":"125","author":"Olawi","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jfma.2024.09.022_bib75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2015.05.127","article-title":"Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone","volume":"200","author":"Lainscak","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.jfma.2024.09.022_bib76","first-page":"363","article-title":"Spironolactone use to treat hypertension: in the right patient groups at the right time","volume":"34","author":"Ziya \u015eener","year":"2018","journal-title":"Acta Cardiol Sin"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.022_bib77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1871525713666150310110934","article-title":"Resistant hypertension in the elderly-second line treatments: aldosterone antagonists, central alpha-agonist agents, alpha-adrenergic receptor blockers, direct vasodilators, and exogenous nitric oxide donors","volume":"12","author":"Musso","year":"2015","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"24","key":"10.1016\/j.jfma.2024.09.022_bib78","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.123.065254","article-title":"Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial","volume":"148","author":"Ostrominski","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jfma.2024.09.022_bib79","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/ajh\/hpaa073","article-title":"Empagliflozin for patients with presumed resistant hypertension: a post hoc analysis of the EMPA-REG outcome trial","volume":"33","author":"Ferreira","year":"2020","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1016\/j.jfma.2024.09.022_bib80","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ajh\/hpaa100","article-title":"SGLT2 inhibitors in resistant hypertension: a sweet solution","volume":"33","author":"Tran","year":"2020","journal-title":"Am J Hypertens"},{"issue":"18","key":"10.1016\/j.jfma.2024.09.022_bib81","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/CIRCULATIONAHA.121.053709","article-title":"Are SGLT2 inhibitors new hypertension drugs?","volume":"143","author":"Kario","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2024.09.022_bib82","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2022.09.050","article-title":"Effectiveness and safety evaluation of sacubitril\/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: a prospective cohort study","volume":"371","author":"Li","year":"2023","journal-title":"Int J Cardiol"},{"issue":"36","key":"10.1016\/j.jfma.2024.09.022_bib83","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/eurheartj\/ehab499","article-title":"Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction","volume":"42","author":"Jackson","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jfma.2024.09.022_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113081","article-title":"Sacubitril\/valsartan in the treatment of resistant hypertension: raising star or illusion?","volume":"11","author":"Tadic","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.022_bib96","first-page":"299","article-title":"Efficacy and safety of renal denervation in elderly patients with resistant hypertension","volume":"86","author":"Ziegler","year":"2015","journal-title":"Cathet Cardiovasc Interv"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462400442X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462400442X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T06:13:34Z","timestamp":1752732814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462400442X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":80,"alternative-id":["S092966462400442X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.09.022","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure targets, medication consideration and unique concerns in elderly hypertension IV: Focus on frailty, orthostatic hypotension, and resistant hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}